SecA protein is directly involved in protein secretion in Escherichia coli  by Kawasaki, Hisashi et al.
Volume 242, number 2, 431-434 FEB 06677 January 1989 
SecA protein is directly involved in protein secretion in Escherichia 
coli 
Hisashi Kawasaki, Shin-ichi Matsuyama, Shoicbi Sasaki, Mitsuru Akita and Shoji Mizusbima 
Institute of Applied Microbiology, The University of Tokyo, Yayoi, Bunkyo-ku, Tokyo 113, Japan 
Received 4 November 1988 
A high-expression plasmid for the secA gene was constructed. The SecA protein was then overproduced in E. coli and 
purified. The purified SecA stimulated the in vitro translccation of a model secretory protein into inverted membrane 
vesicles pretreated with 4 M urea. Membrane vesicles from a secAU mutant exhibited lower translocation activity, which 
was enhanced by SecA. These results indicate that SecA is directly involved in protein secretion across the cytoplasmic 
membrane. 
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1. INTRODUCTION 
A temperature-sensitive(ts) secA mutation was 
first described by Oliver and Beckwith [l] to be 
defective in secretion across the cytoplasmic mem- 
brane of proteins of the outer membrane and the 
periplasmic space in Escherichia co/i. The secA 
gene was mapped at 2.5 min on the E. coli 
chromosomal map [l] and its entire nucleotide se- 
quence was determined [2]. However, the par- 
ticipation of SecA, the secA gene product, in 
protein secretion has not been well demonstrated 
biochemically. 
Recently, we developed an in vitro system that 
exhibits efficient protein translocation into in- 
verted membrane vesicles of E. coli. This was 
achieved by fractionation of the conventional in- 
verted membrane vesicle preparation by means of 
sucrose gradient centrifugation [3] and by the use 
of a model protein possessing an uncleavable 
signal peptide [4]. The uncleavability prevents in 
vitro premature processing of the signal peptide, 
thereby enhancing the translocation efficiency. Us- 
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ing this in vitro translocation system, the re- 
quirements of energy and soluble factors for the 
translocation reaction were studied [3,4]. 
In the present work, using the in vitro transloca- 
tion system, we demonstrated that SecA is directly 
involved in membrane translocation of secretory 
proteins. 
2. MATERIALS AND METHODS 
2.1. Bacterial strains and plasmids 
The E. coli K12 strains used were: MC4100 (F-, araDI36 
A(/ac)Ul69 relA rpsL thrl [S], MM52 (MC4100secAtS) [l] and 
RR1 @ro leu thi lacy hsdR endA rpsL20 aro-14 galK2 xyl-5 
mtl-I supE44) [6]. Plasmid pK107 carries a gene that codes for 
an uncleavable signal peptide-containing OmpF-Lpp chimeric 
protein (uncleavable OmpF-Lpp) [4]. The gene is under the con- 
trol of the SP6 promoter. 
2.2. Preparation of S150-2 extracts and inverted membrane 
vesicles 
Membrane-free SlSO-2 extracts were prepared from E. coli 
MC4100 or MM52 as described in [7]. Purified inverted mem- 
brane vesicles were prepared as described in [3]. 
2.3. Urea treatment of membrane vesicles 
Membrane vesicles (40 fig protein per reaction mixture) were 
treated with 4 M urea and then with 5OrM DCCD 
(N,N ‘-dicyclohexylcarbodiimide) as described in [3] except hat 
membrane vesicles were recovered by centrifugation at 
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350000 x g for 45 min and suspended in 50 mM Tris-acetate 
(pH 7.8)/10% glyceroV8.50lo sucrose. In control experiments, 
membrane vesicles were similarly treated in the absence of urea. 
2.4. Transcription, translation and translocation reactions 
Uncleavable OmpF-Lpp was used as the substrate for 
translocation experiments. In vitro transcription and transla- 
tion in the presence of Tran’sS-label, a mixture of 70% 
[“Slmethionine and 20% [“‘Slcysteine (1000 Ci/mmol, 1 Ci = 
37 GBq), were carried out as described in [4]. The translocation 
reaction was carried out at 40°C and the translocated protein, 
which was proteinase K-resistant, was detected on SDS- 
polyacrylamide gels by fluorography as described in [7]. The 
amount of the radioactive protein was determined den- 
sitometrically with a Toyo DMU-33C. 
2.5. Purification of uncleavable OmpF-Lpp 
After in vitro translation, “S-labeled OmpF-Lpp was 
purified by immunoaffinity chromatography as described in [4] 
and dialyzed against 50 mM Tris-acetate (pH 7.8)/5 mM 
MgS04/2 mM dithiothreitol. 
3. RESULTS AND DISCUSSION 
3.1. Construction of a plasmid carrying the secA 
gene 
An outline of the construction is presented in 
fig.1. A lambda phage clone, 15BlO [8], was used 
as the source of the se& gene. The existence of the 
secA gene in this clone was supported by the posi- 
tion of this gene on the E. coli chromosome map 
[l] and the restriction profiles of the relevant DNA 
regions [8-lo]. The lefthand half of the synthetic 
oligonucleotide linker shown in fig.1 is the 
upstream of the initiation codon on expression vec- 
tor pUSI [ll] and the righthand half was the 
5 ‘-terminus of the secA coding region [2]. 
3.2. Overproduction and purification of SecA 
Upon induction with isopropyl-,&D- 
thiogalactoside (IPTG) of E. coli RR1 carrying the 
secA gene-containing plasmid, pMAN400, a 
100 kDa protein was overproduced (fig.2, lanes 
l-6). Based on its molecular mass and its im- 
munoprecipitability with an anti-SecA antiserum 
(a generous gift from D.B. Oliver) (not shown), we 
conclude that this protein is SecA. Although SecA 
was reported to be a peripheral cytoplasmic mem- 
brane protein [12], the overproduced SecA was 
mainly localized in the cytosol (fig.2, lanes l-6). 
E. coli cells grown in 4 1 of L-broth containing 
1 mM IPTG were disrupted through a French 
pressure cell (8000 psi, 3 times), and the superna- 
tant obtained on high-speed centrifugation 
432 
*ynth*tic oligonucl~otide link*r 
“GATCCTAGGAGGTTTAAATT~TAATCAAATTGTT 
GATCCTCCAAATTTAAATACGATTAGTTTAACAA5~ 
B 
Fig.1. Construction of pMAN400 carrying the highly- 
expressible secA gene. The open box denotes chromosomal 
DNA. The arrow in the open box shows the coding region and 
the direction of transcription of the secA gene. The closed box 
denotes the synthetic oligonucleotide linker. The initiation 
codon ATG of the secA gene is boxed. The restriction 
endonucleases used are shown in parentheses with the following 
abbreviations: E, EcoRI; H, HpaI; B, BarnHI. Cleavage sites 
are also shown. 
(150000 x g for 2.5 h) was dialyzed against 10 mM 
Tris-acetate (pH 7.8)/14 mM Mg-acetate/60 mM 
K-acetate/l mM dithiothreitol and subjected to 
ammonium sulfate fractionation. The 40-50% 
saturation fraction was dialyzed against the buffer 
and then chromatographed on a Sephacryl S-300 
column (100 x 1.6 cm), but dithiothreitol was 
omitted. A fraction which essentially comprised 
pure SecA was obtained (fig.2). 
3.3. Translocation of uncleavable OmpF-Lpp 
with in vitro systems derived from wild-type 
and secAtS cells 
In vitro translocation of uncleavable OmpF-Lpp 
took place efficiently when membrane vesicles and 
S-150 prepared from wild-type cells were used, 
whereas it was poor with those from secA” cells 
(fig.3). The activity in the latter case was, however, 
appreciably stimulated upon the addition of 
purified SecA. The experiment shown in fig.3 was 
performed at 40°C. Essentially the same results 
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Fig.2. Overproduction and purification of SecA. E. coli RR1 
was transformed with pMAN400, and then grown in the 
absence (lanes 1 and 4) and presence (lanes 2 and 5) of 3 mM 
IPTG. Equivalent amounts of the cytosol (lanes l-3) and 
envelope (lanes 4-6) fractions were analyzed on SDS- 
polyacrylamide gels. Lanes 3 and 6 contained RRl, carrying 
pUSI2, grown in the presence of 3 mM IPTG. SecA in the 
cytosol fraction (lane 7) was then purified by ammonium sulfate 
fractionation (lane 8) and Sephacryl S-300 column 
chromatography (lane 9). The arrow indicates SecA. 
were obtained at lower temperatures (not shown), 
indicating that the in vivo ts phenotype was 
reflected only by the weak translocation activity in 
vitro. 
3.4. Purified SecA stimulates in vitro protein 
translocation 
SecA had no effect on translocation when mem- 
brane vesicles from wild-type cells were used 
(fig.4A). It was suggested that 6 M urea causes the 
depletion of SecA in the cytoplasmic membrane 
(Wickner, W., personal communication). 4 M 
urea treatment of membrane vesicles from wild- 
type cells resulted in an almost complete loss of 
translocation activity, which was restored by the 
addition of purified SecA (fig.4B). Since urea 
treatment results in the release of Fr-ATPase 
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Fig.3. Time course of translocation of uncleavable OmpF-Lpp 
with in vitro assay systems derived from wild-type and secA” 
cells. Membrane vesicles (2.5 cg) and SlSO-2 (20 pg) prepared 
from wild-type (0) and XCA’~ (0, A) cells were used for in 
vitro translocation of uncleavable OmpF-Lpp. (A) 0.25 Pg of 
SecA was added. 100% translocation means that all of the 
substrate protein became resistant o proteinase K. 
leading to the formation of a proton channel, 
vesicles thus treated were post-treated with 50 ,uM 
DCCD so that they could generate the proton- 
motive force required for the translocation reac- 
tion [3]. Although restoration of the activity with 
SecA was also observed after treatment with 6 M 
urea, the restoration was not as good as that in the 
case of 4 M urea (not shown). The same amount of 
S-150, as to protein (fig.4B), and a 20-fold excess 
of it (not shown) could not replace SecA at all as 
to the translocation restoration, suggesting that the 
restoration is specific to SecA. 
The amount of SecA required for the restoration 
was then examined (fig.5). With membrane 
vesicles from wild-type cells, about 0.2 ,ug 
SecA/40yg membrane protein was sufficient for 
full activity. When membrane vesicles from secA” 
cells were used, a larger amount of SecA was re- 
quired for the maximum activation. 
The reason for the requirement of excess SecA 
with urea-treated secA” membrane vesicles is not 
well known. The assembly of the mutant SecA in 
the membrane may be unusual, so that the protein 
cannot be extracted with 4 M urea, remaining in 
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Fig.4. SecA stimulates the in vitro translocation into urea- 
treated membrane vesicles. Uncleavable OmpF-Lpp, purified 
on an immunoaffinity column, was translocated at 40°C for 
10 min into urea-untreated (A) or urea-treated membrane 
vesicles (B) prepared from MC4100. The amounts of SecA 
added were 0.25 pg (lane 5) and 1.25 cg (lane 6), and those of 
S150-2 were 0.25pg (lane 3) and 1.25hg (lane 4). PK, 
proteinase K. 
the membrane to compete with the externally add- 
ed wild-type SecA. Studies on the mutant SecA 
may facilitate the understanding of SecA 
functions. 
During the course of this study, we learned that 
D.B. Oliver’s group also purified SecA and per- 
formed biochemical’ studies (personal com- 
munications). 
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Fig.5. Effect of the SecA concentration on restoration of the 
translocation activity of urea-treated membrane vesicles. Urea- 
treated membrane vesicles were prepared from wild-type (0) 
and secA*’ (0) cells, and then translocation of the 
immunopurified uncleavable OmpF-Lpp was performed at 
40°C for 10 min in the presence of the indicated concentrations 
of SecA. 100% translocation indicates the level of translocation 
with urea-untreated membrane vesicles. 
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